Pharmacological interventions for delirium in intensive care patients: A protocol for an overview of reviews

Systematic Reviews

Volumn 5, Issue 1, 2016, Pages

  Barbateskovic, Marija ^a   Larsen, Laura Krone ^a   Oxenbøll Collet, Marie ^a   Jakobsen, Janus Christian ^a,b   Perner, Anders ^a   Wetterslev, Jørn ^a  

^a Rigshospitalet   (Denmark)

^b HOLBÆK HOSPITAL   (Denmark)

Author keywords

Antipsychotics; Critically ill; Delirium; Intensive care unit; Management; Pharmacological interventions; Prevention; Sedatives; Systematic review

Indexed keywords

CHOLINESTERASE INHIBITOR; DEXMEDETOMIDINE; DIAZEPAM; HALOPERIDOL; LORAZEPAM; MIDAZOLAM; MORPHINE; OLANZAPINE; OPIATE; PROPOFOL; QUETIAPINE; RAMELTEON; RISPERIDONE; RIVASTIGMINE; ZIPRASIDONE; HYPNOTIC SEDATIVE AGENT; MELATONIN;

AEROBIC METABOLISM; ARTICLE; BEHAVIOR DISORDER; COGNITIVE DEFECT; DELIRIUM; HALLUCINATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; META ANALYSIS (TOPIC); MORTALITY RATE; PATHOPHYSIOLOGY; PATIENT CARE; PHARMACOLOGICAL PARAMETERS; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SENSITIVITY ANALYSIS; SEQUENTIAL ANALYSIS; SYSTEMATIC REVIEW (TOPIC); CRITICAL ILLNESS; INTENSIVE CARE; METHODOLOGY;

CRITICAL CARE; CRITICAL ILLNESS; DELIRIUM; HUMANS; HYPNOTICS AND SEDATIVES; MELATONIN; META-ANALYSIS AS TOPIC; RESEARCH DESIGN;

EID: 85002712935     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/s13643-016-0391-5     Document Type: Article

References (105)

1. Association AP. Practice Guidelines for the treatment of psychiatric disorders, compendium. 2006.
2. Gunther ML, Morandi A, Ely EW. Pathophysiology of delirium in the intensive care unit. Crit Care Clin. 2008;24(1):45-65.
3. Reade MC, Finfer S. Sedation and delirium in the intensive care unit. N Engl J Med. 2014;370(5):444-54.
4. Meagher DJ, Trzepacz PT. Motoric subtypes of delirium. Semin Clin Neuropsychiatry. 2000;5(2):75-85.
5. Inouye SK. Delirium in older persons. N Engl J Med. 2006;354(11):1157-65.
6. Boorsma M, et al. The prevalence, incidence and risk factors for delirium in Dutch nursing homes and residential care homes. Int J Geriatr Psychiatry. 2012;27(7):709-15.
7. Inouye SK. Delirium in hospitalized older patients. Clin Geriatr Med. 1998;14(4):745-64.
8. Whitlock EL, Vannucci A, Avidan MS. Postoperative delirium. Minerva Anestesiol. 2011;77(4):448-56.
9. Hipp DM, Ely EW. Pharmacological and nonpharmacological management of delirium in critically ill patients. Neurotherapeutics. 2012;9(1):158-75.
10. Casarett DJ, Inouye SK, American College of Physicians-American Society of Internal Medicine End-of-Life Care Consensus Panel. Diagnosis and management of delirium near the end of life. Ann Intern Med. 2001;135(1):32-40.
11. Pandharipande PP, et al. Long-term cognitive impairment after critical illness. N Engl J Med. 2013;369(14):1306-16.
12. Ely EW, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004;291(14):1753-62.
13. Klein Klouwenberg PM, et al. The attributable mortality of delirium in critically ill patients: prospective cohort study. BMJ. 2014;349:g6652. doi: 10.1136/bmj.g6652.
14. Milbrandt EB, et al. Costs associated with delirium in mechanically ventilated patients. Crit Care Med. 2004;32(4):955-62.
15. Gusmao-Flores D, et al. The confusion assessment method for the intensive care unit (CAM-ICU) and intensive care delirium screening checklist (ICDSC) for the diagnosis of delirium: a systematic review and meta-analysis of clinical studies. Crit Care. 2012;16(4):R115.
16. Spronk PE, et al. Occurrence of delirium is severely underestimated in the ICU during daily care. Intensive Care Med. 2009;35(7):1276-80.
17. van Eijk MM, et al. Comparison of delirium assessment tools in a mixed intensive care unit. Crit Care Med. 2009;37(6):1881-5.
18. Peterson JF, et al. Delirium and its motoric subtypes: a study of 614 critically ill patients. J Am Geriatr Soc. 2006;54(3):479-84.
19. Pandharipande P, et al. Motoric subtypes of delirium in mechanically ventilated surgical and trauma intensive care unit patients. Intensive Care Med. 2007;33(10):1726-31.
20. Burry L, et al. Pharmacological interventions for the treatment of delirium in critically ill patients. Cochrane Database Syst Rev. 2015. doi: 10.1002/14651858.CD011749.
21. Barr J, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263-306.
22. Borthwick M, B.R., Craig M, Egan A, Oxley J. Detection, prevention and treatment of delirium in critically ill patients. Intensive Care Society 2006. Available from: http://members.ics.ac.uk/AsiCommon/Controls/BSA/Downloader.aspx?iDocumentStorageKey=d616cece-070a-48a4-bfaa-18da5a546634&iFileTypeCode=PDF&iFileName=Detection,%20Prevention%20and%20Treatment%20of%20Delirium. Accessed Dec 2016.
23. Martin J, et al. Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care--short version. Ger Med Sci. 2010;8:Doc02.
24. Dansk Selskab for Anæstesi og Intensiv Medicin (DASAIM), Sedationsstrategi - Målrette behandling af gener forbundet med kritisk sygdom. 2014. Available from: https://www.google.dk/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=0ahUKEwjSjMmimdPQAhWwbZoKHanCpsQFggaMAA&url=http%3A%2F%2Fwww.dasaim.dk%2Fwp-content%2Fuploads%2F2015%2F09%2FSedationsstrategisept15.pdf&usg=AFQjCNF9xGfr3aoeEBMTTPHrDpBm2BqMSw&bvm=bv.139782543,d.bGs. Accessed Dec 2016.
25. National Clinical Guideline Centre, Delirium: diagnosis, prevention and management. 2010. Available from: https://www.nice.org.uk/guidance/cg103/evidence/full-guideline-134653069. Accessed Dec 2016.
26. Francis J, Delirium and acute confusional states: Prevention, treatment, and prognosis. UpToDate 2014. Accessed Oct 2015.
27. British Geriatrics Society, The prevention, diagnosis and management of delirium in older people - National guideline. 2006. Available from: https://www.rcplondon.ac.uk/file/1619/download?token=YNbPLdOo. Accessed Dec 2016.
28. Meagher DJ, et al. What do we really know about the treatment of delirium with antipsychotics? Ten key issues for delirium pharmacotherapy. Am J Geriatr Psychiatry. 2013;21(12):1223-38.
29. Shehabi Y, et al. Early intensive care sedation predicts long-term mortality in ventilated critically ill patients. Am J Respir Crit Care Med. 2012;186(8):724-31.
30. Golinger RC, Peet T, Tune LE. Association of elevated plasma anticholinergic activity with delirium in surgical patients. Am J Psychiatry. 1987;144(9):1218-20.
31. Han L, et al. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med. 2001;161(8):1099-105.
32. Vaurio LE, et al. Postoperative delirium: the importance of pain and pain management. Anesth Analg. 2006;102(4):1267-73.
33. Bellapart J, Boots R. Potential use of melatonin in sleep and delirium in the critically ill. Br J Anaesth. 2012;108(4):572-80.
34. Olofsson K, et al. Abolished circadian rhythm of melatonin secretion in sedated and artificially ventilated intensive care patients. Acta Anaesthesiol Scand. 2004;48(6):679-84.
35. Ely EW, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA. 2001;286(21):2703-10.
36. Ely EW, et al. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med. 2001;27(12):1892-900.
37. Ely EW, et al. Apolipoprotein E4 polymorphism as a genetic predisposition to delirium in critically ill patients. Crit Care Med. 2007;35(1):112-7.
38. Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014;383(9920):911-22.
39. Girard TD, et al. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med. 2010;38(7):1513-20.
40. Jackson JC, et al. The association between delirium and cognitive decline: a review of the empirical literature. Neuropsychol Rev. 2004;14(2):87-98.
41. van den Boogaard M, et al. Delirium in critically ill patients: impact on long-term health-related quality of life and cognitive functioning. Crit Care Med. 2012;40(1):112-8.
42. Lin SM, et al. The impact of delirium on the survival of mechanically ventilated patients. Crit Care Med. 2004;32(11):2254-9.
43. Pisani MA, et al. Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med. 2009;180(11):1092-7.
44. Halpern NA. Can the costs of critical care be controlled? Curr Opin Crit Care. 2009;15(6):591-6.
45. Laake JH, et al. Impact of the post-World War II generation on intensive care needs in Norway. Acta Anaesthesiol Scand. 2010;54(4):479-84.
46. Devlin JW, et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med. 2010;38(2):419-27.
47. Reade MC, et al. Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial. Crit Care. 2009;13(3):R75.
48. Girard TD, et al. Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial. Crit Care Med. 2010;38(2):428-37.
49. Page VJ, et al. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2013;1(7):515-23.
50. van Eijk MM, et al. Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial. Lancet. 2010;376(9755):1829-37.
51. Hakim SM, Othman AI, Naoum DO. Early treatment with risperidone for subsyndromal delirium after on-pump cardiac surgery in the elderly: a randomized trial. Anesthesiology. 2012;116(5):987-97.
52. Wang W, et al. Haloperidol prophylaxis decreases delirium incidence in elderly patients after noncardiac surgery: a randomized controlled trial*. Crit Care Med. 2012;40(3):731-9.
53. U.S. Food and Drug Administration, Haldol. 2008. Available from: www.accessdata.fda.gov/drugsatfda_docs/label/2008/015923s082,018701s057lbl.pdf. Accessed Dec 2016.
54. Roberts DJ, Haroon B, Hall RI. Sedation for critically ill or injured adults in the intensive care unit: a shifting paradigm. Drugs. 2012;72(14):1881-916.
55. Ho KM, Ng JY. The use of propofol for medium and long-term sedation in critically ill adult patients: a meta-analysis. Intensive Care Med. 2008;34(11):1969-79.
56. Jakob SM, et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA. 2012;307(11):1151-60.
57. Pandharipande PP, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 2007;298(22):2644-53.
58. Riker RR, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA. 2009;301(5):489-99.
59. Atalan N, et al. Morphine is a reasonable alternative to haloperidol in the treatment of postoperative hyperactive-type delirium after cardiac surgery. J Cardiothorac Vasc Anesth. 2013;27(5):933-8.
60. Hudetz JA, et al. Ketamine attenuates delirium after cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2009;23(5):651-7.
61. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. 2011. Available from: www.handbook.cochrane.org. Accessed Dec 2016.
62. Robinson KA, et al. Twelve recommendations for integrating existing systematic reviews into new reviews: EPC guidance. J Clin Epidemiol. 2016;70:38-44.
63. Liberati A, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
64. European Medicines Agency, Guideline for Good Clinical Practice (minor update July 2002). 2002. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002874.pdf. Accessed Dec 2016.
65. Covidence. Available from: https://www.covidence.org/. Accessed Dec 2016.
66. Whiting P, et al. ROBIS: A new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol. 2016;69:225-34.
67. Whiting P, Savovic J, Higgins J, Caldwell D, Reeves B, Shea B, et al. ROBIS: Tool to assess risk of bias in systematic reviews - Guidance on how to use ROBIS. Available from: http://www.bristol.ac.uk/media-library/sites/social-community-medicine/robis/robisguidancedocument.pdf. Accessed Dec 2016.
68. Wetterslev J, et al. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol. 2008;61(1):64-75.
69. Higgins JP, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-60.
70. Jakobsen JC, et al. Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BMC Med Res Methodol. 2014;14:120.
71. Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006;25(20):3443-57.
72. Egger M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-34.
73. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088-101.
74. Review Manager (RevMan) [Computer program]. Version 5.5. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. 2014.
75. Trial Sequential Analysis (TSA) [Computer program on www.ctu.dk/tsa/ ]. Copenhagen Trial Unit 2011.
76. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719-48.
77. Demets DL. Methods for combining randomized clinical trials: strengths and limitations. Stat Med. 1987;6(3):341-50.
78. Higgins JP, Spiegelhalter DJ. Being sceptical about meta-analyses: a Bayesian perspective on magnesium trials in myocardial infarction. Int J Epidemiol. 2002;31(1):96-104.
79. Magnesium in Coronaries (MAGIC) Trial Investigators. Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial. Lancet 2002;360(9341):1189-96.
80. Woods KL, Abrams K. The importance of effect mechanism in the design and interpretation of clinical trials: the role of magnesium in acute myocardial infarction. Prog Cardiovasc Dis. 2002;44(4):267-74.
81. Jakobsen JC, et al. Viewpoint: taking into account risks of random errors when analysing multiple outcomes in systematic reviews. Cochrane Database Syst Rev. 2016;3:Ed000111.
82. Brok J, et al. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol. 2008;61(8):763-9.
83. Brok J, et al. Apparently conclusive meta-analyses may be inconclusive-trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. Int J Epidemiol. 2009;38(1):287-98.
84. Higgins JP, Whitehead A, Simmonds M. Sequential methods for random-effects meta-analysis. Stat Med. 2011;30(9):903-21.
85. Imberger G, et al. Systematic reviews of anesthesiologic interventions reported as statistically significant: problems with power, precision, and type 1 error protection. Anesth Analg. 2015;121(6):1611-22.
86. Mascha EJ. Alpha, beta, meta: guidelines for assessing power and type I error in meta-analyses. Anesth Analg. 2015;121(6):1430-3.
87. Pogue JM, Yusuf S. Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis. Control Clin Trials. 1997;18(6):580-93. discussion 661-6.
88. Terkawi AS, et al. Does ondansetron modify sympathectomy due to subarachnoid anesthesia?: meta-analysis, meta-regression, and trial sequential analysis. Anesthesiology. 2016;124(4):846-69.
89. Thorlund K, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Int J Epidemiol. 2009;38(1):276-86.
90. Gluud C, et al. User manual for trial sequential analysis (TSA) 2011. Available from: http://www.ctu.dk/tsa/files/tsa_manual.pdf. Accessed Dec 2016.
91. Kulinskaya E, Wood J. Trial sequential methods for meta-analysis. Res Synth Methods. 2014;5(3):212-20.
92. Wetterslev J, et al. Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Med Res Methodol. 2009;9:86.
93. Turner RM, Bird SM, Higgins JP. The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews. PLoS One. 2013;8(3):e59202.
94. Guyatt GH, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-6.
95. GRADEpro [Computer program on gradepro.org]: McMaster University. 2014.
96. Lacasse H, Perreault MM, Williamson DR. Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients. Ann Pharmacother. 2006;40(11):1966-73.
97. Rea RS, et al. Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients. Pharmacotherapy. 2007;27(4):588-94.
98. Seitz DP, Gill SS, van Zyl LT. Antipsychotics in the treatment of delirium: a systematic review. J Clin Psychiatry. 2007;68(1):11-21.
99. Devlin JW, Al-Qadhee NS, Skrobik Y. Pharmacologic prevention and treatment of delirium in critically ill and non-critically ill hospitalised patients: a review of data from prospective, randomised studies. Best Pract Res Clin Anaesthesiol. 2012;26(3):289-309.
100. Candy B, et al. Drug therapy for delirium in terminally ill adult patients. Cochrane Database Syst Rev. 2012;11:CD004770.
101. Bathula M, Gonzales JP. The pharmacologic treatment of intensive care unit delirium: a systematic review. Ann Pharmacother. 2013;47(9):1168-74.
102. Perrar KM, Golla H, Voltz R. Pharmacological treatment of delirium in palliative care patients. A systematic literature review. Schmerz. 2013;27(2):190-8.
103. Pasin L, et al. Dexmedetomidine reduces the risk of delirium, agitation and confusion in critically Ill patients: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2014;28(6):1459-66.
104. Al-Qadheeb NS, et al. Randomized ICU trials do not demonstrate an association between interventions that reduce delirium duration and short-term mortality: a systematic review and meta-analysis. Crit Care Med. 2014;42(6):1442-54.
105. Serafim RB, et al. Pharmacologic prevention and treatment of delirium in intensive care patients: a systematic review. J Crit Care. 2015;30(4):799-807.